K-numberK243249
Device nameTriALTIS™ Spine System
ApplicantMedos International SARL
Product codeNKB
Device classClass II
Decision dateJan 17, 2025
DecisionSubstantially Equivalent
Regulation888.3070
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The TriALTIS™ Spine System is a posterior spinal fixation system that provides immobilization and stabilization of the thoracic, lumbar, and sacral spine (T1-S2) as an adjunct to fusion. It consists of bone anchors (screws) connected by longitudinal rods and connectors for treating acute/chronic spinal instabilities, deformities, trauma, degenerative disc disease, and tumors in both skeletally mature and pediatric patients. Fenestrated screws can also be augmented with spinal cement for limited stabilization in advanced tumor cases.

Technological characteristics

The TriALTIS™ System components conform to ASTM F136 and Nitinol to ASTM F2063 standards. The technological evaluation demonstrates that the subject device's intended use, technological characteristics, and performance data are substantially equivalent to predicate devices, with evaluation including component-level testing of interconnection mechanisms using ASTM F1798 for static and fatigue properties.

Test standards cited

ASTM F1798 'Standard Test Method for Evaluating the Static and Fatigue Properties of Interconnection Mechanisms and Subassemblies Used in Spinal Arthrodesis Implants,' specifically addressing axial and torsional grip testing and flexion-extension testing. ASTM F136 and ASTM F2063 for material conformance.

Substantial equivalence argument

The device demonstrates substantial equivalence because its indications for use are identical to the predicate device K242042 (cleared TriALTIS™ Spine System), and non-clinical testing shows that the TriALTIS™ Spine System components perform equivalently to predicate systems (EXPEDIUM connectors) when evaluated on static and fatigue properties of interconnection mechanisms. The technological characteristics and performance data support that this subject device poses no greater risks and provides equivalent clinical benefit compared to the legally marketed predicates.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →